{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:23:35Z","timestamp":1790915015681,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1053\/j.gastro.2006.12.039","type":"journal-article","created":{"date-parts":[[2006,12,21]],"date-time":"2006-12-21T07:24:33Z","timestamp":1166685873000},"page":"1104-1116","source":"Crossref","is-referenced-by-count":236,"title":["Octreotide Inhibits Hepatic Cystogenesis in a Rodent Model of Polycystic Liver Disease by Reducing Cholangiocyte Adenosine 3\u2032,5\u2032-Cyclic Monophosphate"],"prefix":"10.1053","volume":"132","author":[{"given":"Tatyana V.","family":"Masyuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatoliy I.","family":"Masyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente E.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas F.","family":"Larusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2006.12.039_bib1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.1840400404","article-title":"Polycystic disease of the liver","volume":"40","author":"Everson","year":"2004","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2006.12.039_bib2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/01.mnh.0000232888.65895.e7","article-title":"Understanding pathogenic mechanisms in polycystic kidney disease provides clues for therapy","volume":"15","author":"Harris","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1053\/j.gastro.2006.12.039_bib3","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/hep.21199","article-title":"Polycystic liver disease: new insights into disease pathogenesis","volume":"43","author":"Masyuk","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2006.12.039_bib4","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/316904","article-title":"Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1","volume":"67","author":"Reynolds","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.gastro.2006.12.039_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1086\/368295","article-title":"Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease","volume":"72","author":"Li","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.gastro.2006.12.039_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ng1357","article-title":"Mutations in SEC63 cause autosomal dominant polycystic liver disease","volume":"36","author":"Davila","year":"2004","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2006.12.039_bib7","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1053\/j.gastro.2004.02.023","article-title":"Molecular characterization of hepatocystin, the protein that is defective in autosomal dominant polycystic liver disease","volume":"126","author":"Drenth","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2006.12.039_bib8","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1681\/ASN.V1191767","article-title":"Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma","volume":"11","author":"Chauveau","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.gastro.2006.12.039_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/snep.2001.20929","article-title":"The genetics and physiology of polycystic kidney disease","volume":"21","author":"Calvet","year":"2001","journal-title":"Semin Nephrol"},{"key":"10.1053\/j.gastro.2006.12.039_bib10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/340448","article-title":"PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats","volume":"70","author":"Onuchic","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.gastro.2006.12.039_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng833","article-title":"The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein","volume":"30","author":"Ward","year":"2002","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2006.12.039_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ymgme.2003.10.010","article-title":"Molecular genetics of autosomal recessive polycystic kidney disease","volume":"81","author":"Harris","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1053\/j.gastro.2006.12.039_bib13","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1399-3046.2005.00342.x","article-title":"Liver disease in autosomal recessive polycystic kidney disease","volume":"9","author":"Shneider","year":"2005","journal-title":"Pediatr Transplant"},{"key":"10.1053\/j.gastro.2006.12.039_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000200165.90373.9a","article-title":"Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD)","volume":"85","author":"Adeva","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.gastro.2006.12.039_bib15","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/hep.1840400413","article-title":"Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid","volume":"40","author":"Nichols","year":"2004","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2006.12.039_bib16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0168-8278(00)80377-3","article-title":"Regulation and deregulation of cholangiocyte proliferation","volume":"33","author":"Alvaro","year":"2000","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2006.12.039_bib17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2004.06.009","article-title":"cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA\/Src\/MEK\/ERK1\/2 pathway","volume":"41","author":"Francis","year":"2004","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2006.12.039_bib18","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0002-9440(10)62477-7","article-title":"Tannic acid inhibits cholangiocyte proliferation after bile duct ligation via a cyclic adenosine 5\u2032,3\u2032-monophosphate-dependent pathway","volume":"166","author":"Taffetani","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1053\/j.gastro.2006.12.039_bib19","doi-asserted-by":"crossref","first-page":"12984","DOI":"10.1074\/jbc.272.20.12984","article-title":"Secretin promotes osmotic water transport in rat cholangiocytes by increasing aquaporin-1 water channels in plasma membrane","volume":"272","author":"Marinelli","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1053\/j.gastro.2006.12.039_bib20","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jhep.2005.01.001","article-title":"Regulated vesicle trafficking of membrane transporters in hepatic epithelia","volume":"42","author":"Marinelli","year":"2005","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2006.12.039_bib21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/hep.1840110406","article-title":"Functional similarities of hepatic cystic and biliary epithelium: studies of fluid constituents and in vivo secretion in response to secretin","volume":"11","author":"Everson","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2006.12.039_bib22","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1523-1755.2004.00843.x","article-title":"Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells","volume":"66","author":"Belibi","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.gastro.2006.12.039_bib23","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","article-title":"cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells","volume":"11","author":"Hanaoka","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.gastro.2006.12.039_bib24","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat Med"},{"key":"10.1053\/j.gastro.2006.12.039_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(03)00235-9","article-title":"Somatostatin receptors","volume":"1616","author":"Moller","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.gastro.2006.12.039_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1210\/endo-117-1-217","volume":"117","author":"Heisler","year":"1985","journal-title":"Endocrinology"},{"key":"10.1053\/j.gastro.2006.12.039_bib27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1432-1033.1983.tb07192.x","article-title":"Occurrence of an inhibitory guanine nucleotide-binding regulatory component of the adenylate cyclase system in cyc- variants of S49 lymphoma cells","volume":"130","author":"Jakobs","year":"1983","journal-title":"Eur J Biochem"},{"key":"10.1053\/j.gastro.2006.12.039_bib28","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/0016-5085(95)90157-4","article-title":"Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition","volume":"108","author":"Tan","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2006.12.039_bib29","first-page":"1574","article-title":"Somatostatin analogue (octreotide) inhibits bile duct epithelial cell proliferation and fibrosis after extrahepatic biliary obstruction","volume":"143","author":"Tracy","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1053\/j.gastro.2006.12.039_bib30","first-page":"680","article-title":"Octreotide inhibits hepatic fibrosis, bile duct proliferation and bacterial translocation in obstructive jaundice","volume":"50","author":"Turkcapar","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1053\/j.gastro.2006.12.039_bib31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1523-1755.2005.00395.x","article-title":"Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease","volume":"68","author":"Ruggenenti","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.gastro.2006.12.039_bib32","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0002-9440(10)63427-X","article-title":"Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease","volume":"165","author":"Masyuk","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1053\/j.gastro.2006.12.039_bib33","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.gastro.2003.09.001","article-title":"Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat","volume":"125","author":"Masyuk","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2006.12.039_bib34","doi-asserted-by":"crossref","first-page":"9080","DOI":"10.1073\/pnas.90.19.9080","article-title":"Regulation of bicarbonate-dependent ductular bile secretion assessed by lumenal micropuncture of isolated rodent intrahepatic bile ducts","volume":"90","author":"Roberts","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2006.12.039_bib35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/bip.10256","article-title":"Somatostatin analogs and radiopeptides in cancer therapy","volume":"66","author":"Froidevaux","year":"2002","journal-title":"Biopolymers"},{"key":"10.1053\/j.gastro.2006.12.039_bib36","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM199601253340408","article-title":"Octreotide","volume":"334","author":"Lamberts","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2006.12.039_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1677\/jme.0.0250063","article-title":"Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves\u2019 ophthalmopathy","volume":"25","author":"Pasquali","year":"2000","journal-title":"J Mol Endocrinol"},{"key":"10.1053\/j.gastro.2006.12.039_bib38","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1006\/bbrc.1993.1312","article-title":"The rat SSTR2 somatostatin receptor subtype is coupled to inhibition of cyclic AMP accumulation","volume":"191","author":"Strnad","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.gastro.2006.12.039_bib39","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/hep.21143","article-title":"Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases","volume":"43","author":"Fabris","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2006.12.039_bib40","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1471-4159.2004.02402.x","article-title":"Regulation and function of somatostatin receptors","volume":"89","author":"Olias","year":"2004","journal-title":"J Neurochem"},{"key":"10.1053\/j.gastro.2006.12.039_bib41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1999.0183","article-title":"Somatostatin and its receptor family","volume":"20","author":"Patel","year":"1999","journal-title":"Front Neuroendocrinol"},{"key":"10.1053\/j.gastro.2006.12.039_bib42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0928-4257(00)00206-0","article-title":"Signal transduction of somatostatin receptors negatively controlling cell proliferation","volume":"94","author":"Ferjoux","year":"2000","journal-title":"J Physiol Paris"},{"key":"10.1053\/j.gastro.2006.12.039_bib43","doi-asserted-by":"crossref","first-page":"39356","DOI":"10.1074\/jbc.M304524200","article-title":"sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation","volume":"278","author":"Lahlou","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1053\/j.gastro.2006.12.039_bib44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.hepres.2004.02.016","article-title":"Effect of early octreotide administration on the development of esophageal varices in cirrhotic rats","volume":"29","author":"Ballas","year":"2004","journal-title":"Hepatol Res"},{"key":"10.1053\/j.gastro.2006.12.039_bib45","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4065\/80.4.502","article-title":"Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumors","volume":"80","author":"Delaunoit","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.gastro.2006.12.039_bib46","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3109\/02841869709001323","article-title":"Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs","volume":"36","author":"Imam","year":"1997","journal-title":"Acta Oncol"},{"key":"10.1053\/j.gastro.2006.12.039_bib47","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1210\/jcem.86.11.7986","article-title":"Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas","volume":"86","author":"Losa","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.gastro.2006.12.039_bib48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","article-title":"Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease","volume":"10","author":"Torres","year":"2004","journal-title":"Nat Med"},{"key":"10.1053\/j.gastro.2006.12.039_bib49","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1172\/JCI2071","article-title":"Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease","volume":"101","author":"Richards","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1053\/j.gastro.2006.12.039_bib50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1523-1755.2000.00829.x","article-title":"Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor","volume":"57","author":"Sweeney","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/j.gastro.2006.12.039_bib51","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1046\/j.1523-1755.2003.00256.x","article-title":"EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats","volume":"64","author":"Torres","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.gastro.2006.12.039_bib52","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1111\/j.1523-1755.2004.00952.x","article-title":"Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats","volume":"66","author":"Torres","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.gastro.2006.12.039_bib53","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.2353\/ajpath.2006.051136","article-title":"Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib","volume":"169","author":"Sato","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1053\/j.gastro.2006.12.039_bib54","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)","volume":"21","author":"Wahl","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.gastro.2006.12.039_bib55","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508506026898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508506026898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T20:21:49Z","timestamp":1628281309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508506026898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0016508506026898"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2006.12.039","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1081801.534718","asserted-by":"object"}]},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}